181 related articles for article (PubMed ID: 33311478)
1. Delta-secretase triggers Alzheimer's disease pathologies in wild-type hAPP/hMAPT double transgenic mice.
Wu Z; Liu X; Cheng L; Ye K
Cell Death Dis; 2020 Dec; 11(12):1058. PubMed ID: 33311478
[TBL] [Abstract][Full Text] [Related]
2. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
[TBL] [Abstract][Full Text] [Related]
5. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.
Wang J; Hu HJ; Liu ZK; Liu JJ; Wang SS; Cheng Q; Chen HZ; Song M
Transl Neurodegener; 2021 Mar; 10(1):12. PubMed ID: 33789744
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
[TBL] [Abstract][Full Text] [Related]
8. Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.
Wang ZH; Liu P; Liu X; Manfredsson FP; Sandoval IM; Yu SP; Wang JZ; Ye K
Mol Cell; 2017 Sep; 67(5):812-825.e5. PubMed ID: 28826672
[TBL] [Abstract][Full Text] [Related]
9. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
10. Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer's disease.
Xia Y; Wang ZH; Zhang Z; Liu X; Yu SP; Wang JZ; Wang XC; Ye K
Prog Neurobiol; 2021 Sep; 204():102113. PubMed ID: 34166772
[TBL] [Abstract][Full Text] [Related]
11. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease.
Liao J; Chen C; Ahn EH; Liu X; Li H; Edgington-Mitchell LE; Lu Z; Ming S; Ye K
Neuropharmacology; 2021 Oct; 197():108737. PubMed ID: 34343610
[TBL] [Abstract][Full Text] [Related]
12. Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.
Chen C; Zhou Y; Wang H; Alam A; Kang SS; Ahn EH; Liu X; Jia J; Ye K
EMBO J; 2021 Sep; 40(17):e106320. PubMed ID: 34260075
[TBL] [Abstract][Full Text] [Related]
13. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
[TBL] [Abstract][Full Text] [Related]
14. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
15. Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.
Kang SS; Ahn EH; Ye K
Exp Mol Med; 2020 Aug; 52(8):1275-1287. PubMed ID: 32859953
[TBL] [Abstract][Full Text] [Related]
16. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of protein
Feng Y; Jiang H; Li G; He G; Li X
J Neurophysiol; 2022 Apr; 127(4):1067-1074. PubMed ID: 35320023
[TBL] [Abstract][Full Text] [Related]
18. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
[TBL] [Abstract][Full Text] [Related]
19. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
